bromodeoxyuridine has been researched along with tanespimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, K; Behrsing, H; Ip, C; Jimenez, L; Tyson, C | 1 |
| Krishnamurthy, K; Tangpisuthipongsa, D; Wang, G | 1 |
2 other study(ies) available for bromodeoxyuridine and tanespimycin
| Article | Year |
|---|---|
In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin using dog liver slices.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Benzoquinones; Biliary Tract; Biomarkers; Bromodeoxyuridine; Chemical and Drug Induced Liver Injury; Dogs; Immunohistochemistry; In Vitro Techniques; Lactams, Macrocyclic; Liver; Liver Function Tests; Quinones; Rifabutin | 2005 |
Protection of murine neural progenitor cells by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin in the low nanomolar concentration range.
Topics: Animals; Antimetabolites; Benzoquinones; Blotting, Western; Bromodeoxyuridine; Cell Death; Cell Differentiation; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Fluorescent Antibody Technique; HSP90 Heat-Shock Proteins; Lactams, Macrocyclic; Mice; Neural Stem Cells; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2011 |